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The critical shortage of organ donors has greatly l imited the number of 
clinical al lotransplantations. This is part icularly true for neonatal patients, 
for whom xenotransplantation could provide an alternative therapeutic 
option to al lotransplantation. The role of neonatal infant immunity in 
xenotransplantation s ot, however, clearly understood. We examined both 
the proliferative responses of human neonatal ymphocytes to pig aortic 
endothelial cells and serum levels of neonatal natural  antipig xenoantibody. 
Neonatal human lymphocytes and serum were isolated from umbilical cord 
blood. Adult human lymphocytes and serum were used as controls. A 
one-way xenogeneic mixed lymphocyte-endothel ial  cell reaction was per- 
formed, and lymphocyte proliferation was measured by trit iated thymidine 
uptake. Neonatal human lymphocytes recognized and proliferated in 
response to pig aortic endothelial cells (mean 63,926 _ 26,054 counts per 
minute). The level of xenogeneic mixed lymphocyte-endothel ial  cel reac- 
tion of neonatal lymphocytes was significantly lower (p < 0.004) than that 
of adult human lymphocytes (mean 122,444 -+ 33,132 counts per minute). 
An enzyme-linked immunosorbent assay was performed to determine the 
binding of natural  immunoglobulin M and G antibodies to pig endothelial 
cells. Whole-cell enzyme-linked immunosorbent assay demonstrated neo- 
natal human serum to contain very low binding levels of natural  antipig 
immunoglobulin M xenoantibody compared with adult serum. Like adult 
serum, neonatal human serum contained natural  antipig immunoglobulin 
G xenoantibody. Neonatal serum was not cytotoxic to pig endothelial cells, 
suggesting that immunoglobulin G was not the predominant xenoreactive 
antibody. To assess whether neonatal pig endothelial cells also expressed 
xenoantigens, adult and neonatal cultured pig endothelial cells were 
examined by enzyme-linked immunosorbent assay with adult human se- 
rum. Adult human natural  immunoglobulin M xenoantibody recognized 
not only adult pig endothelial cell xenoantigens but also neonatal pig 
endothelial cell xenoantigens. The binding levels of adult natural  antipig 
immunoglobulin M xenoantibodies to adult and neonatal pig endothelial 
cells were similar, suggesting that neonatal pig aortic endothelial cells 
express xenoantigens. The findings of low binding levels of cytotoxic antipig 
immunoglobulin M xenoantibody and low levels of lymphocyte xenoreac- 
tivity to pig endothelial cells in human neonates uggests that pig organs 
may eventually be a suitable source of xenografts for human neonates. 
(J Thorac Cardiovasc Surg 1996;111:920-9) 
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A lthough cardiac al lotransplantation has be- come the therapy of choice for patients with 
end-stage heart disease, the number of patients on 
the waiting list for heart transplantation continues 
to grow. The shortage of donor organs has there- 
fore become the major barrier to the future 
growth of clinical cardiac allotransplantation. 1'2
This predicamen t is particularly true for neonates, 
for whom there are no alternatives to cardiac 
transplantation such as mechanical assist devices. 
For this reason, xenogeneic transplantation has 
been considered as a potential solution to the 
critical shortage of donor organs for the neonatal 
recipient population. 
Pigs represent an attractive choice as xenodo- 
nors because they are readily available, are rela- 
tively easy to breed, represent low risk of 
epizootic disease transmission, and are available 
in all sizes appropriate for use as donors for 
human beings. Although pig cardiac endothelium 
expresses ABO antigens, 3 the immunologic signif- 
icance of this expression is probably small. The 
clinical application of pig xenotransplantation is 
currently, however, limited by hyperacute rejec- 
tion, which occurs within minutes to hours. 4'5 
This immunologic reaction is believed to be me- 
diated primarily by the binding of natural antipig 
xenoantibody to the endothelium of the xenograft, 
with subsequent activation of the complement 
cascade and vascular endothelial cell (EC) injury. 6 
Such an injury results in disruption of the vascular 
endothel ium and microcirculation, interstitial 
hemorrhage, edema, vasospasm, adhesion of 
platelets and fibrin, thrombus formation, and 
myocardial cell ischemic necrosis. 7-9 In experi- 
mental cardiac xenotransplantation, the removal 
of natural antipig xenoantibody by donor organ 
hemoperfusion, 1° plasma exchange, H plasma- 
pheresis, 12 and inhibition of complement 13 has 
resulted in modest prolongation of xenograft sur- 
vival. There have been no in vivo opportunities to 
examine the role of cell-mediated immunity in the 
pathogenesis of distantly related xenotransplanta- 
tion rejection because of the rapid graft loss seen 
with hyperacute rejection. As a surrogate for this 
in vivo experiment, his in vitro study was under- 
taken to examine whether neonatal human lym- 
phocytes can recognize and proliferate in re- 
sponse to pig EC xenoantigens and whether 
neonatal human serum contains natural antipig 
xenoantibodies. Institutional Review Board ap- 
proval ( IRB #0116) by both institutions was ob- 
tained for this study. 
Material and methods 
Preparation of serum samples. Pooled adult human 
blood samples were obtained from healthy volunteers 
from our laboratory (n = 10), and neonatal human blood 
samples were collected from the umbilical veins of normal 
term infants (n = 10). The blood was centrifuged at 800 g 
for 20 minutes, and the serum samples were pooled and 
heat treated for 30 minutes at 56 ° C to inactivate comple- 
ment. The aliquots of these serum samples were then 
stored at -80 ° C. 
Preparation of human peripheral blood leukocytes 
(PBLs). Heparinized adult human peripheral blood was 
obtained from healthy volunteers from our laboratory 
(n = 4), and heparinized neonatal human peripheral 
blood was collected from the umbilical vein of normal 
term infants (n = 10). The blood samples were layered on 
top of Isopaque-Ficoll (Gallard-Schlesinger Industries, 
Inc., New York, N.Y.) and centrifuged. The PBLs were 
harvested and washed twice with Hank's medium (Life 
Technologies, Inc., Gaithersburg, Md.). The viability of 
PBLs was measured by trypan blue dye exclusion and was 
consistently greater than 98%. The cells were then sus- 
pended in RPMI-1640 (Life Technologies). 
Preparation of target cells. Pig aortic ECs were iso- 
lated from both adult and neonatal pig aortas with 
collagenase. These cells were then cultured in Dulbecco's 
modified Eagle medium (Life Technologies) containing 
10% fetal calf serum (Life Technologies) as described by 
Rosiers, Nees, and Gerlach. 14 Subculture of these cells 
was performed in Dulbecco's modified Eagle medium 
containing 10% fetal calf serum. 
Immunoassay. A xenogeneic mixed lymphocyte-EC re- 
action assay (xMLER) was performed to determine the 
immunoreactivity of both adult and neonatal human PBLs 
to cultured pig aortic ECs. A whole-cell enzyme-linked 
immunosorbent assay (ELISA) was performed to deter- 
mine the binding levels of human natural antipig xenoan- 
tibodies. Cytotoxicity of these serum samples to cultured 
pig aortic ECs was measured with a 3-(4,5-dimethylthia- 
zoyl-2-y) 2,5 diphenyl-tetrazolium bromide (MTT) assay. 
xMLER. Cultured pig aortic ECs were transferred to 
separate 96-well plates and irradiated at 3.75 Gy for 5 
minutes. These irradiated pig ECs were used as stimulator 
cells and were cultured with either adult human PBLs or 
neonatal human PBLs in RPMI-1640 medium (Life Tech- 
nologies) supplemented with 10% complement-inacti- 
vated human serum and penicillin (Life Technologies) at 
37 ° C in 5% carbon dioxide for 6 days. On the sixth day, 
the cells were pulse labeled with tritiated thymidine at 1 
/xCi/well for 8 hours and then harvested with a cell 
harvester. Tritiated thymidine incorporation was mea- 
sured with a /3-liquid scintillation counter. Adult human 
PBLs were tested at 5 × 10 4 cells/well, 1 × 10 5 cells/well, 
and 2 × 10 5 cells/well. Neonatal human PBLs were tested 
at 2 × 10 5 cells/well. Responder cells alone and stimulator 
cells alone were used as negative controls. The results 
were expressed as counts per minute of triplicate samples. 
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Fig. 1. Determination of appropriate number of responder cells for proliferative response to cultured pig 
ECs in xMLER. A, The proliferative response of adult human subject r s  PBLs to pig ECs was detected at 
5 x 104 cells/well and reached extremely high levels at 20 × 104 cells/well. B, The xMLER showed an 
extremely strong proliferation from adult human subject 2's PBLs in response to pig ECs at 20 × 10 4 
cells/well. 
Cellular ELISA. Binding levels of natural antipig xeno- 
antibodies to cultured pig aortic ECs was measured by 
ELISA, as previously described by Platt and colleagues. 15
Cultured pig aortic ECs were transferred to separate 
flat-bottom 96-well plates and grown to confluence. These 
cultured pig EC monolayers were fixed with 0.01% glu- 
taraldehyde for 5 minutes and then washed three times 
with cold (40 ° C) phosphate-buffered saline solution 
(PBS). After the final wash, the cells were incubated for 60 
minutes with 1% bovine serum albumin (Sigma Chemical 
Co., St. Louis, Mo.) in PBS at 40 ° C to block the nonspe- 
cific binding of antibodies. 
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Fig. 2. The xMLER demonstrates proliferation of human adult lymphocytes in response to cultured pig 
ECs (2 × 10 5 lymphocytes/well). 
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Fig. 3. The xMLER demonstrates proliferation of human neonatal lymphocytes in response to cultured 
pig ECs (2 x 10 5 lymphocytes/well). 
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Fig. 4. Comparison of immune responses of PBLs (2 × 105 cells/well) from human adults (n = 4) and 
neonates (n = 10) in response to cultured pig ECs in xMLER. Human neonates demonstrate lower levels 
of PBL proliferation than seen in human adults (p < 0.004). 
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Fig. 5. Binding of human natural IgM xenoantibody to cultured pig aortic ECs was measured by ELISA. 
Unlike adult human serum, neonatal human serum contains extremely low levels of natural antipig IgM 
xenoantibodies bound to cultured pig ECs (background 0.2). 
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Fig. 6. The binding of human natural antipig IgG xenoantibodies to cultured pig ECs was determined by 
ELISA (background 0.104). 
Serially diluted samples of both neonatal and adult 
human serum were then added to plates containing fixed 
cultured pig aortic EC monolayers. The incubation was 
carried out at 40 ° C for 60 minutes, and the pig ECs were 
then washed three times with cold PBS. A secondary 
antibody (goat antihuman immunoglobulin M [IgM] or 
immunoglobulin G [IgG; Organon Teknika Corp., 
Durham, N.C.]) conjugated with alkaline phosphatase was 
then added to the plates. Samples were incubated at room 
temperature for 60 minutes, rewashed three times with 
PBS, and developed for 30 minutes in the dark with 1 
mg/ml P-nitrophenyl phosphate and 100 mmol/L dieth- 
anolamine in 0.5 mmol/L magnesium chloride (Sigma). 
The optical density was measured at 405 nm with an 
ELISA reader. A 1% bovine serum albumin solution was 
used as a negative control. 
MTT assay. The cytotoxicity of both adult and neonatal 
human sera to pig aortic ECs was measured with the MTT 
assay (3-(4,5-dimethylthiazoyl-2-y) ,5 diphenyl-tetrazo- 
lium bromide; Sigma) described by Mosmann. 16 Instead 
of measuring dead cells with chromium 51-release assay, 
the tetrazolium salt MTT assay was used to measure the 
activity of living cells by means of mitochondrial dehydro- 
genase activity (mitochondrial dehydrogenases of viable 
cells cleave the tetrazolium ring). Cultured pig aortic ECs 
were transferred into flat-bottom 96-well tissue culture 
plates and grown to confluence. The cell monolayers were 
incubated with 50 /xl adult or neonatal human serum 
samples and 50/xl rabbit complement (Gentak, Plymouth 
Meeting, Pa.) at 37 ° C for 4 hours. The cells were gently 
washed twice with Hank's medium (Life Technologies) 
and then with stock MTT solution (10 /xl per 100 /xl 
medium), and EC culture medium was added to each well 
(total volume 100/xl/well). The plates were incubated at 
37°C for 4 hours. After the final incubation, the MTT 
solution was removed and 100 /xl of acid-isopropanol 
(Sigma) was added to each well to dissolve the purple 
MTT formazan crystals. The plates were measured with 
multiwell scanning spectrophotometers (ELISA readers) 
at 595 nm. Pig EC culture medium (10% fetal calf serum 
in Dulbecco's modified Eagle medium) was used as neg- 
ative control. Rabbit antithymocyte globulin was used as 
positive control. Rabbit antithymocyte globulin produced 
100% cytotoxicity to pig ECs (trypan blue dye exclusion), 
and this was compared with 100% cell lysis caused by cell 
lysis buffer (Fisher Scientific Co., Orangeburg, N.Y.). 
Percentage viability of pig ECs was calculated as fol- 
lows: Percentage of viability = 100% × (Measured sample 
- Positive control)/(Negative control - Positive control). 
Statistical methods. Student's t test was used to analyze 
paired data. 
Results 
Proliferative response of human PBLs to pig ECs. 
In this in vitro study, we initially assessed the 
kinetics of the adult human cel l -mediated immune 
react ion to pig EC membrane antigens in a one-way 
xMLER.  We demonstrated that the cultured pig 
aortic ECs strongly st imulated human PBLs as 
ant igen-presenting cells. The kinetics of the cellular 
react ion from adult  human subjects 1 and 2, as 
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Fig. 7. Viability of cultured pig aortic ECs after incubation with adult or neonatal human serum and rabbit 
complement was measured by MTT assay in antithymocyte globulin (A), culture medium (B), adult human 
serum (C), and neonatal human serum (D). Neonatal human serum demonstrates xtremely low levels of 
cytotoxicity, in contrast to extremely high levels of cytotoxicity observed with adult human serum. 
shown in Fig. 1, demonstrate hat proliferative im- 
mune response is a function of the number of 
responder cells. An extremely high proliferative 
level was noted at 2 × 105 responder cells/well. As 
shown in Fig. 2, adult human PBLs from all subjects 
tested showed extremely high levels of proliferation 
in response to cultured pig aortic ECs (2 × 10 5 
cells/well). 
Proliferation of neonatal human PBLs to cul- 
tured pig aortic ECs. The proliferation of neonatal 
human PBLs (2 x 10 s cells/well) to cultured pig 
aortic ECs was examined with xMLER. The results 
demonstrated that, like adult human PBLs, neonatal 
human PBLs recognize and proliferate in response 
to cultured pig ECs (Fig. 3); however, the prolifer- 
ative responses of these neonatal human PBLs were 
significantly lower than those of adult human PBLs 
(Fig. 4). 
Neonatal human serum lacks natural xenoreac- 
tive antibodies. Cellular ELISA with adult human 
serum samples demonstrated high binding levels of 
natural antipig IgM xenoantibodies to cultured pig 
EC monolayers. The binding of natural IgG anti- 
bodies to cultured pig ECs was also noted in adult 
human serum samples. Similar binding affinities 
were observed for IgM and IgG antibodies to pig 
ECs. 
In contrast o adult human serum, neonatal hu- 
man serum demonstrated extremely low binding 
levels of natural IgM xenoantibodies to cultured pig 
ECs (Fig. 5). The binding of neonatal human IgG 
antibodies to pig ECs was lower than that in adult 
serum (Fig. 6). 
Cytotoxicity by MTT assay. Pooled adult human 
sera demonstrated an extremely high degree of 
cytotoxicity to pig ECs in the presence of rabbit 
complement. In contrast, pooled neonatal human 
sera demonstrated only minimal cytotoxicity to cul- 
tured pig ECs (Fig. 7). Incubation of rabbit comple- 
ment and culture medium with cultured pig ECs did 
not result in cytotoxicity, as determined by trypan 
blue dye exclusion. 
Neonatal pig aortic ECs express xenoantigens. 
As shown in Fig. 8, the binding of adult human 
natural IgM xenoantibodies to neonatal pig aortic 
ECs was similar to that observed with adult pig ECs. 
Discussion 
Hyperacute r jection remains the major barrier to 
the use of distantly related xenografts in clinical 
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as measured by ELISA. 
transplantation. The hyperacute r jection reaction is 
dependent on the binding of natural xenoreactive 
antibody to vascular EC xenoantigens, followed by 
the activation of complement. 6' 17, lS IgM, immuno- 
globulin A, and immunoglobulin D,19' 2o in contrast 
to IgG, are unable to cross the placental barrier 
because of their large size (the molecular weight of 
IgM is approximately 900,000 daltons). We there- 
fore reasoned that because natural antipig IgM 
xenoantibodies are either absent or present at ex- 
tremely low levels in neonatal human serum, cellular 
immune responses may actively participate in the 
rejection of pig-to-human xenografts. This hypothe- 
sis is supported by our finding that cultured pig 
aortic ECs are potent stimulators of human PBLs. 
Of interest is the observation that the lymphocyte 
proliferative response of human neonates i signifi- 
cantly lower than that of human adults. This obser- 
vation can be explained in part by studies howing 
that human cord blood contains a relatively large 
number of suppressor CD4+ T cells. 2123 In addi- 
tion, cell-mediated cytotoxicity has been shown to be 
deficient in the human eonate. 24-a6 On the basis of 
these findings and our in vitro proliferative r sults, it 
appears that the immune systems of human neo- 
nates may be more readily manipulated than those 
of human adults to accept pig xenografts. 
Neonatal human humoral immunity directed 
against distantly related xenografts, uch as those 
from the pig, have not been previously studied. We 
have now demonstrated that neonatal human serum 
contains extremely ow levels of IgM compared with 
the serum of human adults. In addition, these data 
show a high binding level of IgG antibodies to pig 
ECs in the adult, in contrast o a relatively lower 
binding level of IgG antibodies een with neonatal 
human serum. This finding is consistent with Wang's 
observation 27 of selective placental transfer of IgG2 
antibody subclass to the fetus. The functional signif- 
icance of this finding in the human neonate, how- 
ever, remains unclear. 
Adult human serum produced extremely high 
levels of cytotoxicity to cultured pig ECs, as deter- 
mined by MTT assay. This finding correlates with 
high binding levels of natural IgM antibodies to pig 
ECs. In contrast, neonatal human serum produced 
low cytotoxicity to cultured pig ECs, which corre- 
lated with low binding levels of natural IgM xeno- 
antibodies. These findings uggest that human nat- 
ural antipig cytotoxic xenoantibodies are primarily 
IgM in nature and that xenograft rejection in human 
neonates (in whom IgM is very low or absent) is 
probably not entirely dependent on humoral immu- 
nity. This interpretation is supported by previous 
data from our laboratory, which demonstrate hat 
human and baboon IgG antibodies bind to cultured 
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pig ECs and lymphocytes without cell lysis, is' 2s This 
natural model of antipig IgM xenoantibody deple- 
tion may therefore prevent hyperacute rejection of 
xenografts from pig to human neonates. It is impor- 
tant to note that the question of whether cultured 
neonatal pig ECs express xenoantigens on their cell 
membranes is incompletely resolved. In addressing 
this question, we showed by ELISA that human 
antipig xenoreactive antibodies recognize both adult 
pig ECs and neonatal pig ECs. The binding levels of 
natural IgM xenoantibodies to both cell lines were 
similar, suggesting that aortic ECs of the neonatal 
pig, like those of the adult pig, do express xenoan- 
tigens on their cell membranes. 
The fact that neonatal baboon serum, like neona- 
tal human serum, contains extremely low levels of 
natural antipig cytotoxic IgM xenoantibodies led us 
to transplant neonatal pig hearts heterotopically 
into the necks of neonatal baboon recipients. His- 
tologic examinations of the functioning grafts ex- 
cised at 15, 81, 82, 82, and 87 hours after transplan- 
tation demonstrated normal myocardium without 
evidence of hyperacute rejection. Immunohisto- 
chemical studies established no deposition of IgM 
or IgG xenoantibody, C3, C4, or C5b on the EC 
surface of the xenografts, although there was focal 
deposition of platelets and fibrin. Serum samples col- 
lected from recipients before and after transplantation 
revealed normal levels of serum complement. 29-31 
These results further strengthen our hypothesis that 
pig-to-neonatal human xenotransplantation may 
eventually be feasible. 
The application of heart transplantation to hu- 
man neonatal infants is still limited by the severe 
shortage of donor organs. Xenografts may provide 
one solution to this problem, but only if hyperacute 
rejection can be overcome. This study provides 
preliminary insight into the humoral and cellular 
immune phenomena seen with xenografts from pigs 
to newborn human beings. 
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